What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - News FADAM collaborates with Research institute in a non-lucrative act FADAM Association (Angel Manzanares’ Relatives and friends), which fights to improve the living of child with cancer and their relatives, presenting law projects, organising non-lucrative events and helping parents at same situation, celebrated recently the first FADAM event, which allowed to colle News Dr. Reventós lectures on innovation and transfer of public research results in the productive sector Dr. Jaume Reventós, head of the Biomedical Research and Translational Oncology at Vall d'Hebron Research Institute (VHIR) lectures in Santiago de Compostela, Spain, on innovation and transfer of publich research results in the productive sector. During his presentation, Dr. Reventós spoke of entrepr News Dr. Rello participates at Semicyuc The head of the Critical Care Service at Vall d’ Hebron hospital, Dr. Jordi Rello, participated in the National congress of Spanish society in intensive critical medicine and coronary unities (Semicyuc) held in Málaga.Dr. Rello, who coordinates the European register of A Influenza serious cases, was News Dr. Comella at the Societat Catalana de Biologia Dr Joan X. Comella, director of Vall d'Hebron Research Institute (VHIR), participateS on the 18th of June in the annual day of the signposting cellular and metabolism section organised by Societat Catalunya de Biologia (Catalan Biologic Society).His intervention is titled as “Physiological function News Described for the first time an essential protein for nervous system's development Researchers of VHIR and Universidad Autonoma of Barcelona have described for the first time a new protein function (FLIP-L), essential for the nervous system development.Until now, this protein was said to be a security mechanism for programmed cell death. This group of researchers has studied its News 'Nens en moviment' keeps on succeeding Nens en moviment' ('Kids moving') program, coordinated by the research group of pediatric endocrinology (directed by Dr. Antonio Carrascosa, also responsible of the pediatric area of Vall Hebron hospital), has been granted with 'Naos' estrategy prize in sanitary area. The prize is granted by Heath M News Metiladenosin disables melanoma'as proliferation An article published in the last number of BMC Cancer shows the therapeutic potencial of metiladenosin, thanks to an investigation lead by Dr. J. A. Recio, from Pathologic Anatomy service of Vall d’ Hebron News Hospital Vall d'Hebron Research Institute initiates major partnership in the field of novel biomarkers in rheumatoid arthritis Vall d'Hebron Research Institute (VHIR) and TcLand Expression have entered a strategic partnership on the development of new biomarkers for predicting the response to treatment in Rheumatoid Arthritis (RA). TcLand Expression will grant the exclusive and worldwide access to VHIR’s intellectual prope News The eyes of diabetic patients have less vitamin C Researchers at the Institut de Recerca Hospital Vall d'Hebron (VHIR) described for the first time a deficiency of vitamin C in the eye of diabetic patients suffering from diabetic retinopathy. The shortfall of this important antioxidant in the eye may explain, in part, why there are more eye damage News Identified the first genetic variant that predicts response to treatment of hepatitis C Vall d’Hebron Research Institute has participated in a study that has identified the first genetic variant of hepatitis C (IL28B), able to predict whether a patient will have a good or poor response to treatment. "The IL28B allows us to differentiate very well between patients who will do well with News The Gunnar Nilsson's Cancer Foundation visits the Vall d'Hebron Research Institute Members of the Gunnar Nilsson's Cancer Foundation have visited the Vall d’Hebron Research Institute (IR-HUVH) to meet the members of the Laboratory of Hormone-dependent Cancers at the Biomedical Research Unit (URB).Gunnar Nilsson was a Swedish F1 racing driver who died of testicular cancer in 1978. News Neuroinflammation and its impact in Acute Ischemic Stroke and Alzheimer Disease Dr. Joan Montaner, coordinator of the Neurovascular Group at the Vall d’Hebron Research Institute, will participate in the ‘Uriach Sponsored Satellite Symposium’ about “Neuroinflammation and its impact in Acute Ischemic Stroke and Alzheimer Disease”, inside the XIX European Stroke Conference on 27 M News Fragments de HER2, lligats a resposta terapèutica en mama Joaquín Arribas y Manel Esteller, del Instituto de Oncología Valle de Hebrón y el Instituto de Investigación Biomédica de Bellvirge, respectivamente, han explicado las principales conclusiones de sus estudios apoyados por las ayudas a la investigación de la AECC.Diario Médico. Dimecres, 18 de Febrer News El Vall d'Hebrón distingue a sus jóvenes promesas La investigación básica en España ha pasado de ser una rareza a conformar un área fundamental en todos los grandes centros hospitalarios. En unos pocos años, España ha pasado de la fuga de cerebros a la contratación de grandes investigadores, y la creación de grandes centros de investigación. Ésa fu News Una región del cromosoma 13 influye en el riesgo de esclerosis múltiple Investigadores del Hospital Universitario del Valle de Hebrón, de Barcelona, publican en PLoS One un estudio que podría dar una clave para hallar la causa de la esclerosis múltiple, una enfermedad neurodegenerativa hasta ahora de origen desconocido. En concreto, han descrito que una región del cromo News El ministre de Sanitat visita la Unitat de Neuroinmunologia de Vall d'Hebron El ministro de Sanidad y Consumo, Bernat Soria, lanzó ayer un mensaje de optimismo y esperanza respecto al uso de las teràpias celulares, determinantes para el tratamiento de enfermedades como la eslerosis múltiple. News Cèl.lules tumorals que perden la seva immortalitat Investigadores del Valle de Hebrón han abierto la puerta a una interesante nueva vía de abordaje terapéutico del cáncer: transformar en mortales células tumorales e impedir así su crecimiento incontrolado. Diario Médico. Divendres, 6 de Febrer de 2009. C.F. Barcelona News La COX2 protege el corazón en caso de isquemia Potenciar, en vez de inhibir, la COX2 tiene efectos cardioprotectores frente a la isquemia, según un equipo de la red RecavaCarmen Fernández Barcelona 03/03/2009La actividad de la ciclooxigenasa 2 (COX2), una enzima que desempeña un papel crucial en la respuesta inflamatoria, tiene un potente efecto News Las apneas en obeso mórbido con diabetes 2, más graves Un equipo del Valle de Hebrón publica en PLoS-One que las apneas del sueño son más profundas y graves en los obesos mórbidos con diabetes tipo 2 que en los que no tienen esta patología asociada, lo que sugiere la importancia de extremar el control sobre ellos. News Acreditación del Carlos III, ¿para qué? La pregunta del millón estos días en torno a los cinco primeros institutos de investigación biomédica vinculados a hospitales que ha acreditado el Instituto Carlos III es esta: ¿Para qué? Los representantes de los centros agraciados, tras superar un duro y largo proceso de evaluación externa, explic Pagination First page « Previous page ‹ … Page 162 Page 163 Current page 164 Page 165 Page 166 … Next page › Last page »
